SUMMARY: We tested effects of praziquantel, an antischistosomal compound, on clinical and immunological parameters of chronic schistosomiasis japonica. Two Japanese patients, who had high antibody titers to Schistosoma japonicum antigens but no fecal schistosome eggs or no or mild symptoms complained, were treated with praziquantel. Within two years after treatment, anti-schistosome antibodies in sera from the patients became negative in enzyme-linked immunosorbent assay. There was no significant alteration in cellular immunity to the parasite. Although S. japonicum infection is believed to have been eradicated in Japan, our present results seem to suggest the possiblity that a few Japanese individuals, who have high anti-schistosome antibody, still harbor live parasites. The two patients tested (P-1 and P-2) are summarized in Table I . Both were born and grown in Nirasaki City, Yamanashi Prefecture. Their infection with S. japonicum was clearly shown by previous stool examinations or rectal biopsy. P-1 was treated with sodium antimony tartarate 24 years ago, but the treatment was incomplete because of the severe side effects. P-2 had no past history of antischistosomal treatment.
As shown in Table I , although they had slight hyperbilirubinemia, no or some subjective mild symptoms were complained. They had high titers of IgG Ab to S. japonicum egg antigen as well as adult worm antigen ( Fig. 1 ). In comparison with other inhabitants of the same endemic focus in Nirasaki, their Ab titers were extremely high. Because P-1 and P-2 had past history of only insufficient or no treatment for schistosomiasis, they were treated with praziquantel at daily doses of 50 mg/kg for P-1 and 40 mg/kg for P-2.
Several immunological and clinical parameters before and after treatment were compared. ELISA tests were made on cryopreserved sera obtained 0, 1, 3, 6, 12 and 24 months after treatment. All sera were tested at the same time with the antigens from schistosome eggs and adult worms. Specific Ab to poliovirus were also titrated on the same sera obtained from the two patients by the neutralization test. Schistosome antigen-driven in vitro proliferation of peripheral blood lymphocytes (PBL) was analyzed by the method described elsewhere (2).
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We observed remarkable changes in the Ab titer for both patients in ELISA tests. Although the two patients had very high IgG Ab titers before treatment, the titers began to decrease after treatment and finally became negative 24 months after treatment (Fig. 1) . As for IgE Ab, the skin-test reactivity of P-1 was shown to be positive before treatment. Two years after treatment, it became negative. These results indicate that there was a change in the titers of S. japonicum-specific IgG and IgE Ab after tratment with praziquantel.
We observed, however, no change in the neutralizing Ab titer to poliovirus in the sera from the two patients.
There was no alteration in the Ab titer either to S. japonicum egg or adult antigen in individuals without praziquantel treatment during the same period (Fig. 2) .
We tested in vitro cellular response to S. japonicum egg or adult antigen.
Both patients showed vigorous proliferative response of PBL to the schistosome antigens.
When we compared their responsiveness between pre-and posttreatment, there was no significant change, and they still showed strong cellular response to schistosome antigens after treatment (Table II) .
We re-examined the patients for clinical signs a year after treatment. The abnormal findings before treatment were improved except for ultrasonic examination of the liver (Table I ). The egg in the specimens obtained by rectal biopsy still remained one year after treatment. Persistence of deposited schistosome eggs in the rectum tissue for a long period have been well documented by biopsy and surgical specimens from chronic or anamnestic human cases. It is also generally accepted that schistosome eggs persist in the tissue of experimental animals for several years after sufficient treatment.
The present study suggests that praziquantel treatment has effects on the parasite-specific Ab response in patients with chronic schistosomiasis japonica.
The mechanisms for such a phenomenon are not clear. Praziquantel is a highly effective anti-schistosomal compound with few side effects and commonly used in endemic areas of schistosomiasis japonica (3,4). Several researchers have followed time-course kinetics of Ab titers after treatment (5,6). In the Philippine population, Ab titers to S. japonicum egg and adult antigens clearly went down after treatment (5). In experimental animal studies, there are reports showing the same results as those in human cases (7, 8) , although some researchers described no relationship between praziquantel treatment and Ab titers (9) . Those results suggest that elimination of the parasites resulted in diminished Ab titers. It might be, thus, possible to assume that the parasites were still alive in these two accepted that infection with S. japonicum has been eradicated in Japan since there is no human case with egg positive in stool examination and no infected snail host has been found in the survey in this decade. It is likely, however, that stool examination could be negative in cases of very mild infection. Our present observation might suggest the possibility that S. japonicum worms still remain in some individuals in Japan although the worms seem very few. Schistosomes were shown to survive for more than 10 years in infected hosts (10) .
There is evidence to show that praziquantel has effects on the immune regulation mechanisms of infected hosts (11, 12 
